End-of-day quote
Other stock markets
|
||
- EUR | - |
05-08 | Eurobio Scientific: agreement with Myriad Genetics | CF |
05-08 | Eurobio Scientific to Buy Gene Expression Test for Breast Cancer | MT |
Chart calendar Diaxonhit SA
Upcoming events on Diaxonhit SA
Past events on Diaxonhit SA
10/04/2024 16:40 | Q4 2023 Earnings Release |
29/01/2024 | Q4 2023 Sales and Revenue Release After hours |
11/10/2023 17:52 | Q2 2023 Earnings Release |
24/07/2023 18:45 | Q2 2023 Sales and Revenue Release - Turnover |
13/06/2023 08:00 | Annual General Meeting |
04/04/2023 | Q4 2022 Earnings Release Pre-market |
23/01/2023 16:45 | FY 2022 Sales and Revenue Release - Turnover |
10/10/2022 | Interim 2022 Earnings Release Pre-market |
24/07/2022 | Interim 2022 Sales and Revenue Release - Turnover |
12/06/2022 | Annual General Meeting |
06/04/2022 06:30 | FY 2021 Earnings Release |
24/01/2022 16:45 | FY 2021 Sales and Revenue Release - Turnover |
12/10/2021 16:35 | Interim 2021 Earnings Release |
26/07/2021 16:45 | Interim 2021 Sales and Revenue Release - Turnover |
13/04/2021 | FY 2020 Earnings Release After hours |
25/01/2021 16:45 | FY 2020 Sales and Revenue Release - Turnover |
15/10/2020 16:35 | Interim 2020 Earnings Release |
22/06/2020 | Annual General Meeting |
14/04/2020 07:00 | FY 2019 Earnings Release |
27/01/2020 17:19 | FY 2019 Sales and Revenue Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 59,1 58,7 0.68% | 189 0,00 - | 184 182 0.99% | 153 153 0.07% | 130 130 -0.08% | 138 |
EBITDA Million EUR | Released Forecast Spread | 7,00 0,00 - | 88,2 82,6 6.78% | 0,00 0,00 - | 40,5 43,5 -6.9% | 27,3 26,7 2.25% | 29,1 |
EBIT Million EUR | Released Forecast Spread | 3,40 3,70 -8.11% | 84,0 78,7 6.73% | 72,9 76,1 -4.2% | 30,9 38,7 -20.24% | 22,5 22,8 -1.32% | 25,3 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Net income Million EUR | Released Forecast Spread | 0,00 0,00 - | 73,5 72,2 1.8% | 0,00 0,00 - | 24,9 26,6 -6.25% | 4,80 10,1 -52.48% | 9,80 |
EPS EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,43 2,46 -1.22% | 0,43 0,90 -52.22% | 0,95 |
Announcement Date | 14/04/20 | 29/04/21 | 06/04/22 | 05/04/23 | 10/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 S1 |
---|---|---|
Net sales Million EUR | Released Forecast Spread | 95,7 98,0 -2.35% |
Announcement Date | 26/07/21 |
15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Diaxonhit SA
29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
14/05/2024 21:05 | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- ALERS Stock
- ALEHT Stock
- Calendar Diaxonhit SA